New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Immigrants living in US have fewer preterm births; US-born Black pregnant people have highest preterm birth rate

Immigrants living in US have fewer preterm births; US-born Black pregnant people have highest preterm birth rate

byNorthwestern UniversityCredit: CC0 Public DomainPreterm birth rates are an important marker in assessing a country's overall health, and the United States isn't faring very well.Indivi
OB & GYN January 15,2024
Immigrants living in US have fewer preterm births; US-born Black pregnant people have highest preterm birth rate

Immigrants living in US have fewer preterm births; US-born Black pregnant people have highest preterm birth rate

byNorthwestern UniversityCredit: CC0 Public DomainPreterm birth rates are an important marker in assessing a country's overall health, and the United States isn't faring very well.Indivi
OB & GYN January 15,2024
Novel T cell receptor therapy shows early anti-tumor activity

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A
Oncology January 15,2024
Novel T cell receptor therapy shows early anti-tumor activity

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A
Oncology January 15,2024
Nonsurgical treatment for uterine fibroids

Nonsurgical treatment for uterine fibroids

by Sonya Goins, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainUterine fibroids are the leading cause of women undergoing hysterectomies, leaving them unable to bear children. Fibroids often
OB & GYN January 15,2024
Nonsurgical treatment for uterine fibroids

Nonsurgical treatment for uterine fibroids

by Sonya Goins, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainUterine fibroids are the leading cause of women undergoing hysterectomies, leaving them unable to bear children. Fibroids often
OB & GYN January 15,2024
More accurate biomarkers needed to ensure melanomas are spotted

More accurate biomarkers needed to ensure melanomas are spotted

byUniversity of South AustraliaCredit: AI-generated imageNew biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of Sou
Oncology January 15,2024
More accurate biomarkers needed to ensure melanomas are spotted

More accurate biomarkers needed to ensure melanomas are spotted

byUniversity of South AustraliaCredit: AI-generated imageNew biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of Sou
Oncology January 15,2024
New model predicts 10-year breast cancer risk

New model predicts 10-year breast cancer risk

byUniversity of OxfordSmoothed calibration plots of the alignment between predicted and observed risks for each of the models The red lines correspond to the calibration curve, with the red shad
Oncology January 15,2024
New model predicts 10-year breast cancer risk

New model predicts 10-year breast cancer risk

byUniversity of OxfordSmoothed calibration plots of the alignment between predicted and observed risks for each of the models The red lines correspond to the calibration curve, with the red shad
Oncology January 15,2024
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

by Impact JournalsCaspase inhibitors (CI) selectively protect normal cells from chemotherapy-induced apoptosis, without protection multidrug-resistant cancer cells. Flavopiridol (shown in red, as a cy
Oncology January 15,2024
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

by Impact JournalsCaspase inhibitors (CI) selectively protect normal cells from chemotherapy-induced apoptosis, without protection multidrug-resistant cancer cells. Flavopiridol (shown in red, as a cy
Oncology January 15,2024
New device can detect cancer cells without invasive and expensive surgery

New device can detect cancer cells without invasive and expensive surgery

byUniversity of Technology, SydneyThe Static Droplet Microfluidic device. Credit: Dr. Majid WarkianiResearchers from the University of Technology Sydney have developed a new device that can dete
Oncology January 15,2024
New device can detect cancer cells without invasive and expensive surgery

New device can detect cancer cells without invasive and expensive surgery

byUniversity of Technology, SydneyThe Static Droplet Microfluidic device. Credit: Dr. Majid WarkianiResearchers from the University of Technology Sydney have developed a new device that can dete
Oncology January 15,2024
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research
Oncology January 15,2024
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

by Impact Journals LLCOverall survival- log rank test was used; fifteen of the 19 GH-high patients died, the median OS was 9.26 months (95% CI: 7.59, 14.59). Credit: 2022 Mohamed et al.A new research
Oncology January 15,2024
Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs
Oncology January 15,2024
Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs
Oncology January 15,2024
Novel AI blood test detects liver cancer

Novel AI blood test detects liver cancer

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center re
Oncology January 15,2024
Novel AI blood test detects liver cancer

Novel AI blood test detects liver cancer

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainA novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center re
Oncology January 15,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com